X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (696) 696
Paper (556) 556
Publication (365) 365
Report (33) 33
Data Set (4) 4
Conference Proceeding (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (588) 588
particle physics (554) 554
high energy physics - experiment (511) 511
physics (509) 509
physics - high energy physics - experiment (484) 484
high energy physics (342) 342
phenomenology (214) 214
physical sciences (172) 172
fysik (171) 171
cern lhc coll (170) 170
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (158) 158
physics of elementary particles and fields (158) 158
nuclear experiment (155) 155
experimental results (153) 153
particle physics - experiment (147) 147
natural sciences (146) 146
naturvetenskap (146) 146
hep (140) 140
subatomär fysik (105) 105
subatomic physics (104) 104
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (101) 101
hadron-hadron scattering (90) 90
scattering [p p] (85) 85
p p: scattering (78) 78
physics, particles & fields (74) 74
p p: colliding beams (72) 72
ex (70) 70
13000 gev-cms (64) 64
elementary particles, quantum field theory (62) 62
quantum field theories, string theory (62) 62
astrophysics (61) 61
colliding beams [p p] (60) 60
8000 gev-cms (57) 57
high energy astrophysical phenomena (56) 56
science & technology (56) 56
ciências físicas [ciências naturais] (52) 52
humans (47) 47
large hadron collider (46) 46
detectors (45) 45
background (43) 43
collisions (43) 43
index medicus (41) 41
male (36) 36
astronomy, astrophysics and cosmology (35) 35
classical and quantum gravitation, relativity theory (34) 34
quantum physics (34) 34
female (33) 33
nuclear and high energy physics (33) 33
atlas (32) 32
physics and astronomy (31) 31
astronomy & astrophysics (30) 30
measurement science and instrumentation (29) 29
middle aged (29) 29
nuclear energy (29) 29
parton distributions (29) 29
física (28) 28
nuclear physics, heavy ions, hadrons (28) 28
adult (27) 27
engineering (27) 27
hep-ex (27) 27
mass dependence (27) 27
decay (25) 25
luminosity (25) 25
instrumentation and detectors (24) 24
supersymmetry (24) 24
settore fis/01 - fisica sperimentale (23) 23
data analysis method (22) 22
lhc (22) 22
standard model (22) 22
transverse momentum (22) 22
nuclear physics (21) 21
settore fis/04 - fisica nucleare e subnucleare (21) 21
物理学 (21) 21
model (20) 20
particle collisions (20) 20
searching (20) 20
transverse momentum dependence (20) 20
aged (19) 19
infectious diseases (19) 19
kinematics (19) 19
protons (19) 19
nucl (18) 18
channel cross section: branching ratio: upper limit (17) 17
cross sections (17) 17
física nuclear (17) 17
bosons (16) 16
hadron colliders (16) 16
physics, nuclear (16) 16
physik (16) 16
quarks (16) 16
channel cross section: upper limit (15) 15
pair production (15) 15
rapidity dependence (15) 15
cern lab (14) 14
electroweak interaction (14) 14
higgs bosons (14) 14
hiv (14) 14
jets (14) 14
leptonic decay [z0] (14) 14
leptons (14) 14
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 12/2006, Volume 12, Issue 24, pp. 7374 - 7379
Journal Article
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, p. e83018
Over the past years BARD1 (BRCA1-associated RING domain 1) has been considered as both a BRCA1 (BReast Cancer susceptibility gene 1, early onset) interactor... 
TRANSLOCATION | APOPTOSIS | HISTONE DEACETYLASE INHIBITOR | MS-275 | MULTIDISCIPLINARY SCIENCES | INTERFERENCE | MICRORNAS | IDENTIFICATION | CANCER | CARCINOMA | VORINOSTAT | Humans | Leukemia, Myeloid, Acute - metabolism | Gene Expression Regulation, Leukemic - drug effects | MicroRNAs - metabolism | RNA, Neoplasm - metabolism | Ubiquitin-Protein Ligases - biosynthesis | Protein Isoforms - biosynthesis | U937 Cells | Tumor Suppressor Proteins - genetics | K562 Cells | HL-60 Cells | Leukemia, Myeloid, Acute - drug therapy | RNA, Neoplasm - genetics | Histone Deacetylase Inhibitors - pharmacology | Epigenesis, Genetic - drug effects | MicroRNAs - genetics | Tumor Suppressor Proteins - biosynthesis | Ubiquitin-Protein Ligases - genetics | Hydroxamic Acids - pharmacology | Leukemia, Myeloid, Acute - genetics | Protein Isoforms - genetics | Epigenetic inheritance | MicroRNA | Gene mutations | Genes | Disease susceptibility | Genetic aspects | Ovarian cancer | Cancer | Histone deacetylase | Laboratories | Leukemia | Lung cancer | Biochemistry | mRNA | DNA repair | Cell growth | Cell cycle | miRNA | Deoxyribonucleic acid--DNA | Hematology | BRCA1 protein | Myeloid leukemia | Gynecology | Breast cancer | Biophysics | Mammals | Gene expression | Obstetrics | Pathology | MicroRNAs | Medical prognosis | Stem cells | Epigenetics | Tumor suppressor genes | Diagnostic systems | Mutation | Acute myeloid leukemia | Apoptosis | Deoxyribonucleic acid | DNA
Journal Article
Journal Article
Journal Article
Journal Article
Infection, ISSN 0300-8126, 2/2018, Volume 46, Issue 1, pp. 77 - 82
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 06/2018, Volume 18, Issue 1, pp. 285 - 11
Background: Triple-drug regimens are the gold standard for HIV therapy. Nucleos(t) ide reverse transcriptase inhibitors (NRTIs) reducing regimens are used to... 
Inflammation | Dual-therapy | HIV | Switch | Antiretroviral therapy | VITAMIN-D | INFECTIOUS DISEASES | PLUS LAMIVUDINE | POSITIVE PATIENTS | CARDIOVASCULAR-DISEASE EVENTS | RENAL-DISEASE | SYSTEMIC INFLAMMATION | TENOFOVIR DISOPROXIL FUMARATE | IMMUNE ACTIVATION | DOUBLE-BLIND | TO-LYMPHOCYTE RATIO | HIV Infections - blood | Tenofovir - therapeutic use | Humans | Middle Aged | Inflammation - virology | Male | Treatment Outcome | Atazanavir Sulfate - therapeutic use | CD4-CD8 Ratio | HIV Infections - complications | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Italy | Dideoxynucleosides - therapeutic use | Retrospective Studies | Reverse Transcriptase Inhibitors - therapeutic use | Antiretroviral Therapy, Highly Active - methods | Darunavir - therapeutic use | Cohort Studies | Prevention | Antiviral agents | Highly active antiretroviral therapy | Usage | Care and treatment | HIV patients | Dosage and administration | HIV (Viruses) | Health aspects | HIV infection | Therapy | Lipids | Infections | Activation | Cancer therapies | Subgroups | Reduction | Acquired immune deficiency syndrome--AIDS | Metabolites | Antiretroviral agents | Lymphocytes | Human immunodeficiency virus--HIV | Bone density | Trends | Drug therapy | Creatinine | Antiretroviral drugs | Cytokines | Neutrophils | Vitamin deficiency | Metabolism | Patients | Cholesterol | Protease inhibitors | Clinical medicine | Kidney diseases
Journal Article
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, ISSN 2296-4185, 01/2020, Volume 7
Journal Article